Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
R Rajasingham, RM Smith, BJ Park… - The Lancet infectious …, 2017 - thelancet.com
Background Cryptococcus is the most common cause of meningitis in adults living with HIV
in sub-Saharan Africa. Global burden estimates are crucial to guide prevention strategies …
in sub-Saharan Africa. Global burden estimates are crucial to guide prevention strategies …
The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis
R Rajasingham, NP Govender, A Jordan… - The Lancet infectious …, 2022 - thelancet.com
Background Cryptococcal meningitis is the most common cause of meningitis in adults living
with HIV in sub-Saharan Africa. The estimates of national, regional, and global burden of …
with HIV in sub-Saharan Africa. The estimates of national, regional, and global burden of …
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
BJ Park, KA Wannemuehler, BJ Marston, N Govender… - Aids, 2009 - journals.lww.com
Objective: Cryptococcal meningitis is one of the most important HIV-related opportunistic
infections, especially in the developing world. In order to help develop global strategies and …
infections, especially in the developing world. In order to help develop global strategies and …
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries
A Loyse, J Burry, J Cohn, N Ford, T Chiller… - The Lancet Infectious …, 2019 - thelancet.com
In 2018, WHO issued guidelines for the diagnosis, prevention, and management of HIV-
related cryptococcal disease. Two strategies are recommended to reduce the high mortality …
related cryptococcal disease. Two strategies are recommended to reduce the high mortality …
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out
Cryptococcosis is now the most common cause of adult meningitis in much of Southern and
East Africa [1]. Despite currently available antifungal therapies, acute mortality ranges from …
East Africa [1]. Despite currently available antifungal therapies, acute mortality ranges from …
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy
Background. Cryptococcal meningitis (CM) is the proximate cause of death in 20%–30% of
persons with acquired immunodeficiency syndrome in Africa. Methods. Two prospective …
persons with acquired immunodeficiency syndrome in Africa. Methods. Two prospective …
Cryptococcal meningoencephalitis: time for action
Cryptococcal meningoencephalitis was first described over a century ago. This fungal
infection is preventable and treatable yet continues to be associated with excessive …
infection is preventable and treatable yet continues to be associated with excessive …
Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries
A Loyse, H Thangaraj, P Easterbrook… - The Lancet infectious …, 2013 - thelancet.com
Cryptococcal meningitis is the leading cause of adult meningitis in sub-Saharan Africa, and
contributes up to 20% of AIDS-related mortality in low-income and middle-income countries …
contributes up to 20% of AIDS-related mortality in low-income and middle-income countries …
Epidemiology of cryptococcal meningitis in the US: 1997–2009
V Pyrgos, AE Seitz, CA Steiner, DR Prevots… - PloS one, 2013 - journals.plos.org
Cryptococcal meningitis (CM) causes significant morbidity and mortality globally; however,
recent national trends have not been described. Incidence and trends for CM-associated …
recent national trends have not been described. Incidence and trends for CM-associated …
Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa
Objectives Cryptococcal meningitis (CM)-related mortality may be prevented by screening
patients for sub-clinical cryptococcal antigenaemia (CRAG) at antiretroviral-therapy (ART) …
patients for sub-clinical cryptococcal antigenaemia (CRAG) at antiretroviral-therapy (ART) …
相关搜索
- updated analysis cryptococcal meningitis
- updated analysis global burden
- global burden cryptococcal meningitis
- hiv aids cryptococcal meningitis
- low income cryptococcal meningitis
- antiretroviral therapy cryptococcal meningitis
- combined cohort cryptococcal meningitis
- antigen screening cryptococcal meningitis
- cryptococcal infection modelling analysis
- patients in harare cryptococcal meningitis
- determinants of mortality cryptococcal meningitis
- guidelines for the management cryptococcal meningitis
- human immunodeficiency cryptococcal meningitis
- cost effectiveness cryptococcal meningitis
- global burden cryptococcal infection
- global burden modelling analysis